Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT01767623 |
Title | A Study of The Impact of Severe Hepatic Impairment on the Pharmacokinetics and Safety of Vemurafenib in BRAF V600 Mutation-Positive Cancer Patients |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | Yes |
Sponsors | Hoffmann-La Roche |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA | TUR | ISR | GRC | GBR | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
California Cancer Associates for Research & Excellence, Inc. | Encinitas | California | 92008 | United States | Details | |
Peninsula and South Eastern Haematology and Oncology Grou | Frankston | Victoria | 3199 | Australia | Details | |
District General Hospital of Athens Laiko; 1st Internal Medicine Clinic | Athens | 11527 | Greece | Details | ||
Rambam Health Care Campus | Haifa | 31096 | Israel | Details | ||
Tel Aviv Sourasky Medical Center | Tel Aviv | 64239 | Israel | Details | ||
SBIH " Clinical Oncological Dispensary # 1"; Chemotherapy department #1 and #2 | Krasnodar | 350040 | Russian Federation | Details | ||
Ege University Medicine Develoment and Pharmacokinetics Research Center; Pulmonary Diseases | Izmir | 35040 | Turkey | Details | ||
Velindre Cancer Centre | Cardiff | CF14 2TL | United Kingdom | Details |